BARCELONA, Spain, Nov. 4, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest albumin ...
AMSTERDAM — A weekly albumin infusion, in addition to standard medical treatment, significantly improves survival in patients with advanced liver cirrhosis, results from the ANSWER study show. Albumin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback